EasyGo!™ Human IL-8 One-Step ELISA Kit 检测试剂盒(酶联免疫吸附法)
¥2,190.00 – ¥3,650.00
- 分子靶点:CXCL8, IL-8, GCP1, NAP1
- 种属:人 (Human)
- 样本类型:血清,血浆
- 检测样本体积:10 μL
- 灵敏度:3.85 pg/mL
- 检测范围:15.625 pg/mL - 1000 pg/mL
- 回收率:85% - 122%
在售SKU:70-EK108EGA-48, 70-EK108EGA-96, EK108EGA, 人白细胞介素8, 白细胞介素8, 白细胞介素, 人, 白介素, 8, 一步法, 一步法ELISA, 一步法试剂盒, 一步法ELISA试剂盒
描述
商品名 |
EasyGo!™ Human IL-8 One-Step ELISA Kit 检测试剂盒(酶联免疫吸附法) |
---|---|
检测方法 |
双抗夹心法 |
精密度 |
板内变异系数:6.1% - 9.5%;板间变异系数:8.9% - 9.8% |
样本类型 |
血清,血浆 |
检测样本体积 |
10 μL |
灵敏度 |
3.85 pg/mL |
检测范围 |
15.625 pg/mL - 1000 pg/mL |
回收率 |
85% - 122% |
平均回收率 |
1.02 |
板式 |
96孔板,可拆 |
保存 |
试剂盒未拆开,2 - 8℃保存。已拆开,标准品-20℃保存,其它2 - 8℃保存。 |
运输条件 |
4℃蓝冰运输 |
组分 |
|
检测原理:本试剂盒采用双抗体夹心酶联免疫吸附检测技术。特异性捕获抗体预包被在高亲和力的酶标板上,酶标板孔中预先加入生物素标记的微球和辣根过氧化物酶微球。酶标板孔中加入标准品和待测样本,经过孵育,样本中存在的待测物质与捕获抗体和检测抗体结合。洗涤去除未结合的物质后,加入显色底物(TMB),避光显色。颜色反应的深浅与样本中待测物质的浓度成正比。加入终止液终止反应,在 450 nm 波长 (参考波长 5630 nm) 测定吸光度值。
![EasyGo!™ Human IL-8 One-Step ELISA Kit EasyGo!™ 人白细胞介素8 (IL-8) 一步法酶联免疫吸附测定试剂盒 - 标准曲线](https://www.liankebio.com/wp-content/uploads/EK10EGA8-01.jpg)
分子信息
CXCL8 分子靶点信息概述
- 分子名:CXCL8, C-X-C motif chemokine ligand 8
- 基因家族:Chemokine ligands; Interleukins
- 别名:SCYB8; LUCT; LECT; MDNCF; TSG-1; IL-8; NAP-1; 3-10C; MONAP; AMCF-I; LYNAP; NAF; b-ENAP; GCP-1; K60; GCP1; NAP1
- 曾用名:IL8
- 全称:neutrophil-activating peptide 1; granulocyte chemotactic protein 1; monocyte-derived neutrophil chemotactic factor; lung giant cell carcinoma-derived chemotactic protein; tumor necrosis factor-induced gene 1; monocyte-derived neutrophil-activating peptide; lymphocyte derived neutrophil activating peptide; beta endothelial cell-derived neutrophil activating peptide; alveolar macrophage chemotactic factor I; interleukin 8; chemokine (C-X-C motif) ligand 8
CXCL8 分子靶点综述
白细胞介素8(IL-8)是由巨噬细胞和其它类型细胞如上皮细胞、气道平滑肌细胞和内皮细胞产生的趋化因子,在人类中,由IL8基因编码。IL-8可有效促进血管生成,在细支气管炎的发病机制中起重要作用。IL-8可通过对中性粒细胞的召集和脱颗粒来实现对炎症反应的调节,可作为结肠癌细胞株的自分泌生长因子来作用于结肠直肠癌。高水平的IL-8可减少精神分裂症患者抗精神病药的阳性反应。另外,IL-8与肥胖和囊性纤维化的发病机制也相关。
人 Human CXCL8 分子靶点信息
- 分子名:CXCL8, C-X-C motif chemokine ligand 8
- 别称:
- alveolar macrophage chemotactic factor I
- beta endothelial cell-derived neutrophil activating peptide
- beta-thromboglobulin-like protein
- C-X-C motif chemokine 8
- chemokine (C-X-C motif) ligand 8
- emoctakin
- GCP-1
- GCP1
- granulocyte chemotactic protein 1
- IL8
- interleukin 8
- interleukin-8
- LECT
- LUCT
- lung giant cell carcinoma-derived chemotactic protein
- lymphocyte derived neutrophil activating peptide
- lymphocyte-derived neutrophil-activating factor
- LYNAP
- MDNCF
- MONAP
- monocyte-derived neutrophil chemotactic factor
- monocyte-derived neutrophil-activating peptide
- NAF
- NAP-1
- NAP1
- neutrophil-activating peptide 1
- SCYB8
- small inducible cytokine subfamily B, member 8
- T cell chemotactic factor
- T-cell chemotactic factor
- tumor necrosis factor-induced gene 1
- 基因序列:NCBI_Gene: 3576
- 蛋白序列:UniProtKB: P10145
人 Human CXCL8靶点分子功能(预测)
Enables chemokine activity and interleukin-8 receptor binding activity. Involved in several processes, including cellular response to cytokine stimulus; induction of positive chemotaxis; and neutrophil chemotaxis. Acts upstream of or within negative regulation of cell adhesion molecule production; positive regulation of cellular biosynthetic process; and regulation of gene expression. Predicted to be located in extracellular region. Predicted to be active in extracellular space. Implicated in several diseases, including autoimmune uveitis; bacterial gastritis; gastrointestinal system cancer (multiple); trachoma; and urinary tract infection. Biomarker of several diseases, including chikungunya; cholestasis (multiple); cystic fibrosis; liver disease (multiple); and tuberculosis (multiple).
引用文献